Why is "Progeria" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-13 21:14:41
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Progeria entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-13 and was most recently seen on 2026-05-13.
Wikipedia Overview
Progeria is a type of progeroid syndrome. A single gene mutation is responsible for causing progeria. The affected gene, known as lamin A (LMNA), makes a protein necessary for holding the cell nucleus together. When this gene mutates, an abnormal form of lamin A protein called progerin is produced. Progeroid syndromes are a group of diseases that cause individuals to age faster than usual. People born with progeria typically live until their mid- to late-teens or early twenties. Severe cardiovascular complications usually develop by puberty, later on resulting in death.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Press Release Service: The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria - CRISPR Medicine News
-
Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome - PR Newswire
-
DNA-Protein Crosslinks Explain Accelerated Aging in Progeria - the-scientist.com
-
Forge Biologics Agrees to Develop and Manufacture Gene Therapy for Progeria - Genetic Engineering and Biotechnology News
-
Battling a Disease That Brutally Ages Young Bodies - The New Yorker
-
New RNA therapy reverses symptoms of progeria in mouse models - News-Medical
-
A gene from 100-year-olds could help kids who age too fast - ScienceDaily
-
Woman Talks Living with Rapid-Aging Disease (Exclusive) - People.com
-
October: Healthy longevity gene progeria | News and features - University of Bristol
-
Nicotinamide Mononucleotide Alleviates Aging Defects in Hutchinson–Gilford Progeria Syndrome - Wiley
-
Progeria Research Foundation, Forge Biologics Enter Gene Therapy Mfg. Pact - Contract Pharma
-
The accumulation of progerin underlies the loss of aortic smooth muscle cells in Hutchinson-Gilford progeria syndrome - Nature
-
Coming of Age - PhMuseum
-
Living faster than time: 48-year-old woman lives in the body of an 80-year-old - ynetnews
-
Surgical Aortic Valve Replacement Combined With Coronary Artery Bypass Grafting in a Patient With Progeria - JACC Journals
-
‘The Beauty’ Episode 7: Who Plays John Carroll Lynch’s Daughter Joey? Meet Kaylee Halko - Comic Book Club
-
Zokinvy for progeria: Russian сhildren to receive U.S. Drug via ‘Circle of Kindness’ Foundation - Новости GxP
-
Cardiomyocyte-Restricted Expression of Progerin Confers Cardiac Hypertrophy - American Heart Association Journals
-
Sentynl to License Investigational Molecule from PRG S&T for Progeria Treatment - Contract Pharma
-
The Disease that Accelerates Aging in Kids - The New Yorker
-
Exploring Endothelial Dysfunction in Hutchinson-Gilford Progeria Syndrome - Stanford Medicine
-
Researchers develop RNA 'scissors' therapy offering new hope for progeria patients - koreabiomed.com
-
110-Year Longevity Gene Reverses Progeria Aging - 조선일보
-
Peabody races for research - Itemlive
-
In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice - Nature
-
Hutchinson-Gilford Progeria Syndrome, Causes, Treatment, Latest News - Vajiram & Ravi
-
Sam Berns, 17, Whose Life With Progeria Was the Subject of 'Life According to Sam,' Has Died - IMDb
-
Specific inhibition of progerin production through CRISPR-Cas13 editing to treat Hutchinson-Gilford progeria syndrome - BioWorld News
-
A Disease That Makes Children Age Rapidly Gets Closer to a Cure (Published 2024) - The New York Times
-
Zydus Arm Sentynl Licenses Progeria Drug Progerinin, Strengthens Rare Disease Pipeline - Medical Dialogues
-
Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome | Circulation - American Heart Association Journals
-
It’s personal: How the Boston Children’s progeria research community brought new life to an old drug - Boston Children's Answers
-
Recurrent somatic mutation and progerin expression in early vascular aging of chronic kidney disease - Nature
-
Interview: CRISPR Base Editors Offer First One-Time Treatment for the Lethal Premature-ageing Disease Progeria - CRISPR Medicine News
-
Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype - Nature
-
Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome - Nature
-
Hutchinson-Gilford Progeria Syndrome: A Literature Review - Cureus
-
Progeria: From the unknown to the first FDA-approved treatment - American Society for Biochemistry and Molecular Biology
-
Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome - Nature
-
‘Incredible' gene-editing result in mice inspires plans to treat premature-aging syndrome in children - Science | AAAS
-
Base Editing in Progeria - The New England Journal of Medicine
-
Antisense approach slows progeria - Nature
-
US FDA Authorizes Launch of Clinical Trial to Support New Treatment Development for Progeria - BioSpace
-
Progeria study finds base-editing therapy lengthens lifespan in mice - Harvard Gazette
-
The science behind Werner Syndrome: Inside Sinenhlanhla Khoza’s battle with accelerated ageing - IOL
-
Progression of Cardiac Abnormalities in Hutchinson-Gilford Progeria Syndrome: A Prospective Longitudinal Study - American Heart Association Journals
-
DNA-editing method shows promise to treat mouse model of progeria - Medical Xpress
-
Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice - Nature
-
Phasor map analysis to investigate Hutchinson–Gilford progeria cell under polarization-resolved optical scanning microscopy - Nature
-
Sammy Basso, Advocate for Progeria Research, Is Dead at 28 (Published 2024) - The New York Times
-
Failed cancer drug may extend life in children with progeria - Boston Children's Answers
-
Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome - American Heart Association Journals
-
Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion - Nature
-
CRISPR base editor treats premature-aging syndrome | Signal Transduction and Targeted Therapy - Nature
-
Base editor treats progeria in mice - Nature
-
The FDA has approved the first drug to treat the rapid-aging disease progeria - Science News
-
Sammy Basso, progeria advocate, has died at 28 - statnews.com
-
Readily Available Tools to Detect Progerin and Cardiac Disease Progression in Hutchinson-Gilford Progeria Syndrome - American Heart Association Journals
-
One step closer to the first approved treatment for Progeria - statnews.com
-
SAMMY-seq reveals early alteration of heterochromatin and deregulation of bivalent genes in Hutchinson-Gilford Progeria Syndrome - Nature
-
Disorganized chromatin hierarchy and stem cell aging in a male patient of atypical laminopathy-based progeria mandibuloacral dysplasia type A - Nature
-
Circular RNA Telomerase Reverses Endothelial Senescence in Progeria - Qin - 2025 - Aging Cell - Wiley Online Library
-
Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation - Nature
-
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria - Yahoo Finance
-
Pathological modelling of pigmentation disorders associated with Hutchinson-Gilford Progeria Syndrome (HGPS) revealed an impaired melanogenesis pathway in iPS-derived melanocytes - Nature
-
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome - Nature
-
Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome - Nature
-
Decreased vascular smooth muscle contractility in Hutchinson–Gilford Progeria Syndrome linked to defective smooth muscle myosin heavy chain expression - Nature
-
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome - Nature
-
Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome - Nature
-
FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies - PR Newswire
-
Hutchinson–Gilford Progeria Syndrome: Clinical and Molecular Characterization - Dove Medical Press
-
Targeting the progeria mutation - Nature
-
Survey of plasma proteins in children with progeria pre-therapy and on-therapy with lonafarnib | Pediatric Research - Nature
-
After losing son to rare disease at 17, mom helps spur its 1st treatment - TODAY.com
-
Phosphorylated Lamins in Euchromatin: New Clues to Progeria - ScienceDirect.com
-
Research suggests promising drug therapy for premature aging disease - Brown University
-
Epidemiological characteristics of patients with Hutchinson-Gilford progeria syndrome and progeroid laminopathies in China - Nature
-
Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells - Nature
-
Bringing an orphan drug to market - ACS Publications
-
Progeria-based vascular model identifies networks associated with cardiovascular aging and disease - Wiley Online Library
-
CRISPR cures progeria in mice, raising hope for one-time therapy for a disease that causes rapid aging - statnews.com
-
From dye to base editing, early aging may soon have a cure - Drug Discovery News
-
FDA Approves Drug for Progeria, a Rare Disease Causing Rapid Aging in Children - AJMC
-
Phenotype and Course of Hutchinson–Gilford Progeria Syndrome - The New England Journal of Medicine
-
First-Ever Treatment for Rare Rapid-Aging Disease Progeria Receives U.S. FDA Approval - PR Newswire
-
Protein discovery could pave the way for improved treatment of premature aging disease - Medical Xpress
-
A lamin A protein isoform overexpressed in Hutchinson–Gilford progeria syndrome interferes with mitosis in progeria and normal cells - PNAS
-
Local girl who captured community’s heart with humor, bravery while facing rare disease dies at 14 - WTVG
-
Neonatal progeria: increased ratio of progerin to lamin A leads to progeria of the newborn - Nature
-
Base Editing in Progeria - The New England Journal of Medicine
-
Long lifetime and tissue-specific accumulation of lamin A/C in Hutchinson–Gilford progeria syndrome - Rockefeller University Press
-
New target identified for treatment of premature aging disease - Salk Institute for Biological Studies
-
Vietnam’s rarest child inspires a nation with her smile - Báo VietNamNet
-
Zydus Lifesciences' Sentynl to fully own progeria drug Progerinin - NewsBytes
-
Base editor repairs mutation found in the premature-ageing syndrome progeria - Nature
-
DNA-editing method shows promise to treat mouse model of progeria - National Human Genome Research Institute (NHGRI) (.gov)
-
There are 400 children worldwide with progeria, a rapid-aging disease. Now there’s a potential treatment - Genetic Literacy Project
-
Longitudinal Changes in Myocardial Deformation in Hutchinson-Gilford Progeria Syndrome - American Heart Association Journals
-
Impaired end joining induces cardiac atrophy in a Hutchinson–Gilford progeria mouse model - PNAS
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.